Cosmos Health Q1 revenue rises to record

Cosmos Health

21/05/2026 14:25

Overview

US healthcare group's Q1 revenue rose 31% yr/yr to record $17.9 mln

Gross profit fell as revenue mix shifted toward wholesale distribution

Adjusted EBITDA near breakeven as investments offset higher revenue

Outlook

Company says record momentum continues into Q2 2026 with U.S. expansion underway

Cosmos Health expects adjusted EBITDA to turn positive as growth investments drive returns

Result Drivers

SALES MOMENTUM - Co cited broad-based commercial strength, including record distribution volumes at CosmoFarm, increased Sky Premium Life order activity, and expanded contract manufacturing at Cana Laboratories

REVENUE MIX SHIFT - Gross profit declined due to increased wholesale distribution activity at CosmoFarm and a sales discount adjustment

STRATEGIC INVESTMENTS - Operating expenses rose as co invested in personnel, infrastructure, technology, and AI-driven efficiencies to support global growth initiatives

Company press release: ID:nACSMjs8Fa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Miss
$17.9 mln
Q1 Gross Profit
$1.38 mln
Q1 Operating Expenses
$3.57 mln


Analyst Coverage

Wall Street's median 12-month price target for Cosmos Health Inc is $4.50, about 1,482.8% above its May 20 closing price of $0.28

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)